These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24246607

  • 1. Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.
    Pholwat S, Stroup S, Gratz J, Trangan V, Foongladda S, Kumburu H, Juma SP, Kibiki G, Houpt E.
    Tuberculosis (Edinb); 2014 Jan; 94(1):20-5. PubMed ID: 24246607
    [Abstract] [Full Text] [Related]

  • 2. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A.
    BMC Microbiol; 2010 Aug 20; 10():223. PubMed ID: 20727143
    [Abstract] [Full Text] [Related]

  • 3. Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.
    Rahman A, Ferdous SS, Ahmed S, Rahman SMM, Uddin MKM, Pholwat S, Gratz J, Houpt E, Banu S.
    Antimicrob Agents Chemother; 2017 Sep 20; 61(9):. PubMed ID: 28630193
    [Abstract] [Full Text] [Related]

  • 4. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing.
    Tam KK, Leung KS, Siu GK, Chang KC, Wong SS, Ho PL, Leung EK, Yam WC.
    J Clin Microbiol; 2019 Aug 20; 57(8):. PubMed ID: 31189582
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W, Chen J, Shen Y, Jin J, Wu J, Sun F, Wu Y, Xie L, Zhang Y, Zhang W.
    Clin Microbiol Infect; 2018 Sep 20; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P, Yamaguchi T, Mulundu G, Nakajima C, Mbulo G, Solo ES, Fukushima Y, Kasakwa K, Suzuki Y.
    Tuberculosis (Edinb); 2018 Mar 20; 109():117-122. PubMed ID: 29559115
    [Abstract] [Full Text] [Related]

  • 8. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
    Maslov DA, Zaĭchikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN.
    Tuberculosis (Edinb); 2015 Sep 20; 95(5):608-12. PubMed ID: 26071666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP, Maro A, Pholwat S, Mpagama SG, Gratz J, Liyoyo A, Houpt ER, Kibiki GS, Mmbaga BT, Heysell SK.
    BMC Infect Dis; 2019 Feb 07; 19(1):129. PubMed ID: 30732572
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y, Zhu D, Zheng H, Shen J, Hu Y, Liu J, Zhao Y.
    BMC Infect Dis; 2017 Nov 06; 17(1):711. PubMed ID: 29110640
    [Abstract] [Full Text] [Related]

  • 12. [Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis].
    Hong CY, Wang F, Liu XL.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar 06; 36(3):198-201. PubMed ID: 23856143
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015.
    Mansjo M, Werngren J, Hoffner S.
    Int J Mycobacteriol; 2017 Mar 06; 6(2):156-161. PubMed ID: 28559517
    [Abstract] [Full Text] [Related]

  • 17. Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
    Werngren J, Alm E, Mansjö M.
    J Clin Microbiol; 2017 Jun 06; 55(6):1920-1927. PubMed ID: 28404681
    [Abstract] [Full Text] [Related]

  • 18. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
    Li D, Hu Y, Werngren J, Mansjö M, Zheng X, Drobniewski F, Hoffner S, Xu B.
    Antimicrob Agents Chemother; 2016 Sep 06; 60(9):5159-66. PubMed ID: 27297481
    [Abstract] [Full Text] [Related]

  • 19. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT, Malik SI, Ali S, Masood N, Nadeem T, Khan AS, Afzal MT.
    BMC Infect Dis; 2019 Feb 06; 19(1):116. PubMed ID: 30728001
    [Abstract] [Full Text] [Related]

  • 20. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
    Shenai S, Rodrigues C, Sadani M, Sukhadia N, Mehta A.
    Indian J Tuberc; 2009 Apr 06; 56(2):82-90. PubMed ID: 19810590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.